|
RPL7L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64002145197628E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.84425865876892E-12 |
| Normal-vs-Stage2 |
2.37289999999168E-05 |
| Normal-vs-Stage3 |
1.69786407155925E-12 |
| Normal-vs-Stage4 |
5.72708547252887E-12 |
| Stage1-vs-Stage2 |
3.803600E-01 |
| Stage1-vs-Stage3 |
1.442020E-01 |
| Stage1-vs-Stage4 |
1.487810E-02 |
| Stage2-vs-Stage3 |
7.205900E-02 |
| Stage2-vs-Stage4 |
2.043700E-02 |
| Stage3-vs-Stage4 |
3.567400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27595720048157E-14 |
| Normal-vs-AfricanAmerican |
1.176440E-03 |
| Normal-vs-Asian |
2.51570000386891E-08 |
| Caucasian-vs-AfricanAmerican |
1.196630E-01 |
| Caucasian-vs-Asian |
9.773800E-01 |
| AfricanAmerican-vs-Asian |
1.529430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10598205541146E-12 |
| Normal-vs-Female |
1.96476168667914E-12 |
| Male-vs-Female |
9.436100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.42640035736019E-10 |
| Normal-vs-Age(41-60Yrs) |
3.23652216138726E-12 |
| Normal-vs-Age(61-80Yrs) |
4.35407265797494E-12 |
| Normal-vs-Age(81-100Yrs) |
5.175100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.380800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.981440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.586200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.177400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.484000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.500000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.793600E-02 |
| Classical-VS-Follicular |
5.971600E-01 |
| Classical-VS-Other |
1.148020E-01 |
| Classical-VS-Normal |
4.29234425780578E-12 |
| Tall-VS-Follicular |
2.241400E-01 |
| Tall-VS-Other |
3.802600E-01 |
| Tall-VS-Normal |
1.03029995646153E-09 |
| Follicular-VS-Other |
2.467400E-01 |
| Follicular-VS-Normal |
2.42940000338976E-08 |
| Other-VS-Normal |
2.436600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.36550836883043E-12 |
| Normal-vs-N1 |
1.01829988885527E-10 |
| N0-vs-N1 |
5.321900E-02 |
|
|
